SurbhiSidanaMD

PubMed

• 38 citations
  Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma.
  Jennifer M Logue, Lauren C Peres, Hamza Hashmi, Christelle M Colin-Leitzinger, Alexandria M Shrewsbury
  Blood Advances. 2022-12-27
• 84 citations
  Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.
  Doris K Hansen, Surbhi Sidana, Lauren C Peres, Christelle Colin Leitzinger, Leyla Shune
  Journal of Clinical Oncology. 2023-04-10
• 29 citations
  Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
  Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk
  Blood Cancer Journal. 2023-08-09

Journal Articles

• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature

Abstracts/Posters

• Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses
  Surbhi Sidana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis
  Surbhi Sidana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Quality of life (QOL) in patients undergoing CAR-T therapy versus stem cell transplant (SCT). 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
• Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019